These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 33094841)
1. Investigating the missing heritability of fetal haemoglobin level in Africa. Wonkam A Br J Haematol; 2020 Dec; 191(5):668-670. PubMed ID: 33094841 [No Abstract] [Full Text] [Related]
2. Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies. Lettre G; Bauer DE Lancet; 2016 Jun; 387(10037):2554-64. PubMed ID: 27353686 [TBL] [Abstract][Full Text] [Related]
3. The cellular basis of haemoglobin switching: further studies of fetal-to-adult haemopoietic cell transplantation. Wood WG; Bunch C; Kelly S Prog Clin Biol Res; 1985; 191():369-82. PubMed ID: 2413476 [TBL] [Abstract][Full Text] [Related]
4. Impact of Double-Hit and Double-Expressor Phenotypes in Relapsed Aggressive B-Cell Lymphomas Treated With Autologous Hematopoietic Stem Cell Transplantation. Smith SM J Clin Oncol; 2017 Jan; 35(1):1-3. PubMed ID: 28034063 [No Abstract] [Full Text] [Related]
5. Autologous stem cell transplant in first remission for transformed indolent non-Hodgkin lymphoma: additional data to guide practice. Reneau JC; William BM Br J Haematol; 2020 Dec; 191(5):663-665. PubMed ID: 33065776 [No Abstract] [Full Text] [Related]
6. Diffuse large B-cell lymphoma: the challenge of relapse after an autologous stem cell transplant. Robinson SP Bone Marrow Transplant; 2017 Feb; 52(2):199-200. PubMed ID: 27869811 [No Abstract] [Full Text] [Related]
7. Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. Galli E; Sorà F; Hohaus S; Bellesi S; Autore F; Metafuni E; Innocenti I; Marra J; Fresa A; Limongiello MA; Giammarco S; Leccisotti L; Guarneri A; Chiusolo P; Laurenti L; Teofili L; Piccirillo N; Bacigalupo A; Sica S Bone Marrow Transplant; 2022 May; 57(5):837-839. PubMed ID: 35260803 [No Abstract] [Full Text] [Related]
8. Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantation. Ha VH; Ghosh S; Leyshon C; Ryan N; Chambers CR; Stewart DA J Oncol Pharm Pract; 2018 Jul; 24(5):323-331. PubMed ID: 28358279 [TBL] [Abstract][Full Text] [Related]
9. Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma. Tanimoto T; Oshima K; Tsuda K; Mori J; Shimmura H Lancet Oncol; 2017 Oct; 18(10):e557. PubMed ID: 28971816 [No Abstract] [Full Text] [Related]
11. Should patient age be an obstacle for high-dose therapy and stem cell rescue? Dann EJ Leuk Res; 2019 Mar; 78():34-35. PubMed ID: 30711890 [No Abstract] [Full Text] [Related]